A phase I pharmacokinetic (PK) and pharmacodynamic (PD) study of PLX9486 alone and in combination (combo) with the KIT inhibitors pexidartinib (pexi) or sunitinib (su) in patients (Pts) with advanced solid tumors and gastrointestinal stromal tumor (GIST) Meeting Abstract
| Authors: | Wagner, A. J.; Tap, W. D.; Shields, A. F.; Patnaik, A.; Chugh, R.; Tinoco, G.; Michelson, G.; Alcantar, O.; Pelayo, M.; Zhang, C.; Severson, P.; Martin, E.; Trent, J. C. |
| Abstract Title: | A phase I pharmacokinetic (PK) and pharmacodynamic (PD) study of PLX9486 alone and in combination (combo) with the KIT inhibitors pexidartinib (pexi) or sunitinib (su) in patients (Pts) with advanced solid tumors and gastrointestinal stromal tumor (GIST) |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 578s |
| Language: | English |
| ACCESSION: | WOS:000442916003592 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.11509 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 11509 -- Source: Wos |
